$11.11
0.050.45%
At close: -
$11.10
-0.01000-0.09%
After Hours: 6:27 PM EDT
Comments
Loading...
Latest Verve Therapeutics Stock News | NASDAQ:VERV | Benzinga
Get the latest news on Verve Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Verve Therapeutics performance
Categories: All
Wednesday, June 18, 2025
- Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
- This Verve Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
- HC Wainwright & Co. Downgrades Verve Therapeu...
- LifeSci Capital Downgrades Verve Therapeutics...
- Jefferies Downgrades Verve Therapeutics to Ho...
Tuesday, June 17, 2025
- 5 Analysts Assess Verve Therapeutics: What You Need To Know
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday
- William Blair Downgrades Verve Therapeutics t...
- Canaccord Genuity Downgrades Verve Therapeuti...
- Verve Therapeutics shares are trading higher ...
- Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Eli Lilly Expands Into Gene Editing With Verve Therapeutics Acquisition
- Eli Lilly Agrees To Acquire Verve Therapeutic...
- Why Lennar Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Wednesday, May 14, 2025
Wednesday, May 07, 2025
Monday, April 21, 2025
Tuesday, April 15, 2025
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday (CORRECTED)
- Cantor Fitzgerald Upgrades Verve Therapeutics...
- Guggenheim Maintains Buy on Verve Therapeutic...
- Verve Therapeutics shares are trading higher ...
- Canaccord Genuity Maintains Buy on Verve Ther...
Monday, April 14, 2025
- Assessing Verve Therapeutics: Insights From 4 Financial Analysts
- HC Wainwright & Co. Maintains Buy on Verve Th...
- Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose
- Verve Therapeutics shares are trading higher ...
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Verve Therapeutics Reports Results for Heart-...
